newsfilter
← Latest News
GlobeNewswire·

Molecular Templates, Inc. Reports First Quarter 2023 Financial Results and Business Update

Advancing clinical development of MT-6402, MT-8421, and MT-0169, and preclinical activities related to Bristol Myers Squibb collaboration AUSTIN, Texas, May 15, 2023 (GLOBE NEWSWIRE) -- Molecular Templates,